VR Adviser as of June 30, 2023
Portfolio Holdings for VR Adviser
VR Adviser holds 30 positions in its portfolio as reported in the June 2023 quarterly 13F filing
Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
---|---|---|---|---|---|
Miragen Therapeutics (VRDN) | 11.7 | $73M | 3.1M | 23.79 | |
Cogent Biosciences (COGT) | 8.9 | $56M | 4.7M | 11.84 | |
4d Molecular Therapeutics In (FDMT) | 8.7 | $54M | 3.0M | 18.07 | |
Enliven Therapeutics (ELVN) | 7.3 | $46M | 2.2M | 20.41 | |
Merus N V (MRUS) | 7.3 | $46M | 1.7M | 26.33 | |
Gh Research Ordinary Shares (GHRS) | 6.7 | $42M | 3.5M | 11.87 | |
Ambrx Biopharma Sponsored Ads | 6.5 | $41M | 2.5M | 16.46 | |
Kalvista Pharmaceuticals (KALV) | 4.2 | $26M | 2.9M | 9.00 | |
Terns Pharmaceuticals (TERN) | 4.2 | $26M | 3.0M | 8.75 | |
Cabaletta Bio (CABA) | 4.1 | $26M | 2.0M | 12.91 | |
Dyne Therapeutics (DYN) | 3.9 | $25M | 2.2M | 11.25 | |
Celcuity (CELC) | 3.7 | $23M | 2.1M | 10.98 | |
Savara (SVRA) | 3.2 | $20M | 6.4M | 3.19 | |
Pharvaris N V (PHVS) | 3.2 | $20M | 1.3M | 15.14 | |
Rhythm Pharmaceuticals (RYTM) | 2.9 | $18M | 1.1M | 16.49 | |
Oric Pharmaceuticals (ORIC) | 2.7 | $17M | 2.1M | 7.76 | |
Aclaris Therapeutics (ACRS) | 1.7 | $11M | 1.0M | 10.37 | |
Trevi Therapeutics (TRVI) | 1.3 | $8.2M | 3.4M | 2.39 | |
Applied Therapeutics (APLT) | 1.2 | $7.2M | 5.7M | 1.28 | |
Theseus Pharmaceuticals | 1.1 | $7.2M | 770k | 9.33 | |
Milestone Pharmaceuticals (MIST) | 1.0 | $6.3M | 2.2M | 2.85 | |
Adverum Biotechnologies | 1.0 | $6.2M | 3.9M | 1.59 | |
Praxis Precision Medicines I | 1.0 | $6.1M | 5.3M | 1.15 | |
Pliant Therapeutics (PLRX) | 0.8 | $5.2M | 289k | 18.12 | |
Lyra Therapeutics (LYRA) | 0.6 | $3.8M | 924k | 4.11 | |
Aeglea Biotherapeutics | 0.5 | $2.9M | 6.3M | 0.45 | |
Black Diamond Therapeutics (BDTX) | 0.3 | $1.8M | 354k | 5.05 | |
Rallybio Corp (RLYB) | 0.2 | $1.5M | 269k | 5.66 | |
Affimed Therapeutics B V | 0.1 | $855k | 1.4M | 0.60 | |
Avalo Therapeutics Com New | 0.1 | $444k | 1.3M | 0.36 |